Novo Nordisk A/S ADR buy melinda
Start price
01.09.17
/
50%
€43.06
Target price
29.12.17
€49.61
Performance (%)
13.28%
End price
29.12.17
€48.78
Summary
This prediction ended on 29.12.17 with a price of €48.78. The prediction had a final performance of 13.28%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Novo Nordisk A/S ADR | 4.015% | 4.015% | -58.088% | -66.206% |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% | 65.292% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% | 97.467% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% | 39.755% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% | 61.093% |
Comments by melinda for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Insulin-Pen
Diabetes
Trends Technische Analyse Novo Nordisk A / S
kurzfristig mittelfristig langfristig Trends Trosse Trosse Trosse
(Vom Mitglied beendet)
Stopped prediction by melinda for Novo Nordisk A/S ADR
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€158.50
14.05.23
14.05.23
€165.00
14.05.24
14.05.24
-22.71%
15.05.24
15.05.24
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€47.74
01.09.17
01.09.17
€55.00
29.12.17
29.12.17
13.28%
29.12.17
29.12.17
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€37.95
06.07.17
06.07.17
€45.10
29.08.17
29.08.17
11.71%
29.08.17
29.08.17
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€42.07
06.07.17
06.07.17
€50.00
29.08.17
29.08.17
11.71%
29.08.17
29.08.17
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€32.79
17.01.17
17.01.17
€33.37
24.04.17
24.04.17
2.29%
24.04.17
24.04.17